← Leaderboards
Jennifer E Ho
University Of California, San Francisco
$11,062,788
Attributed
$14,164,838
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,164,838 · 8
By mechanism
R01$11,053,249 · 4
T32$1,642,356 · 1
K23$831,600 · 1
K24$612,924 · 1
F32$24,709 · 1
Top collaborators
- Naomi Miriam Hamburg8 shared
- Murray A Mittleman2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Jiandong Liu$9,304,678
- John Daniel Kelly$1,673,513
- David Wells Staudt$598,729
- Priscilla Y. Hsue$28,957,856
- Iris Liu$159,980
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsPathway InteractionsResearch PersonnelPhenotypeCardiovascular SystemFuturePublic Health RelevanceFunctional DisorderObesityCohortLungHeart FailureProspectiveInvestigationFoundationsInsulin ResistanceCommunitiesBioinformaticsLeadParticipantMultidisciplinaryMolecularInsightVascular Diseases
Grant awards (34)
Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease$759,238
R01 · FY2025 · HL
Long-Term Endothelial Effects of COVID-19 in Obesity$678,331
R01 · FY2025 · HL · contact PI
Training Program in Cardiovascular Research$554,554
T32 · FY2025 · HL · contact PI
Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease$729,747
R01 · FY2024 · HL
Long-Term Endothelial Effects of COVID-19 in Obesity$663,087
R01 · FY2024 · HL · contact PI
Training Program in Cardiovascular Research$555,112
T32 · FY2024 · HL · contact PI
Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease$123,849
R01 · FY2024 · HL
Mentoring in Patient-Oriented and Translational HFpEF Research$121,948
K24 · FY2024 · HL · contact PI
Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease$752,931
R01 · FY2023 · HL
Long-Term Endothelial Effects of COVID-19 in Obesity$678,030
R01 · FY2023 · HL · contact PI
Training Program in Cardiovascular Research$532,690
T32 · FY2023 · HL · contact PI
Mentoring in Patient-Oriented and Translational HFpEF Research$121,948
K24 · FY2023 · HL · contact PI
Long-Term Endothelial Effects of COVID-19 in Obesity$731,086
R01 · FY2022 · HL · contact PI
Mentoring in Patient-Oriented and Translational HFpEF Research$121,948
K24 · FY2022 · HL · contact PI
Eicosanoid Profiles as Determinants of HFpEF$592,670
R01 · FY2021 · HL · contact PI
The Association of Metabolic Disease and Pulmonary Hypertension$463,290
R01 · FY2021 · HL · contact PI
Eicosanoid Profiles as Determinants of HFpEF$116,000
R01 · FY2021 · HL · contact PI
The Association of Metabolic Disease and Pulmonary Hypertension$107,401
R01 · FY2021 · HL · contact PI
Mentoring in Patient-Oriented and Translational HFpEF Research$83,934
K24 · FY2021 · HL · contact PI
Mentoring in Patient-Oriented and Translational HFpEF Research$39,606
K24 · FY2021 · HL · contact PI
Eicosanoid Profiles as Determinants of HFpEF$768,855
R01 · FY2020 · HL · contact PI
The Association of Metabolic Disease and Pulmonary Hypertension$570,691
R01 · FY2020 · HL · contact PI
Mentoring in Patient-Oriented and Translational HFpEF Research$123,540
K24 · FY2020 · HL · contact PI
Eicosanoid Profiles as Determinants of HFpEF$768,855
R01 · FY2019 · HL · contact PI
The Association of Metabolic Disease and Pulmonary Hypertension$570,691
R01 · FY2019 · HL · contact PI
Eicosanoid Profiles as Determinants of HFpEF$828,655
R01 · FY2018 · HL · contact PI
The Association of Metabolic Disease and Pulmonary Hypertension$570,691
R01 · FY2018 · HL · contact PI
The Association of Metabolic Disease and Pulmonary Hypertension$579,151
R01 · FY2017 · HL · contact PI
The Role of Galectin-3 in Cardiac Remodeling and Heart Failure$179,280
K23 · FY2017 · HL · contact PI
The Role of Galectin-3 in Cardiac Remodeling and Heart Failure$200,880
K23 · FY2016 · HL · contact PI
The Role of Galectin-3 in Cardiac Remodeling and Heart Failure$157,680
K23 · FY2015 · HL · contact PI
The Role of Galectin-3 in Cardiac Remodeling and Heart Failure$157,680
K23 · FY2014 · HL · contact PI
The Role of Galectin-3 in Cardiac Remodeling and Heart Failure$136,080
K23 · FY2013 · HL · contact PI
The Role of Endothelias Dysfunction in HIV-Associated Pulmonary Hypertension$24,709
F32 · FY2009 · HL · contact PI